Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma. Goyal L, Meric-Bernstam F, Hollebecque A, Valle JW, et al. N Engl J Med 2023;388:228-239.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Goyal L, Meric-Bernstam F, Hollebecque A, Valle JW, et al. Futibatinib for FGFR2-Rearranged Intrahepatic Cholangiocarcinoma. N Engl J Med 2023;388:228-239.
PMID: 36652354